Wegovy clinical studies and reported hair loss percentages Wegovy clinical trials show more notable results: Hair loss affected 3% of adult participants compared to 1% in the placebo group [7] The numbers were higher in children 12 and older, where 4% reported hair loss while the placebo group showed no cases [8] Comparing hair loss rates across different GLP-1 medications GLP-1 medications of all types show distinct patterns: Tirzepatide (Mounjaro): Users reported hair loss rates between 4.9% to 5.7% at doses from 5mg to 15mg [8] Zepbound: The overall rates reached 4% to 5%, with women showing much higher numbers 7.1% compared to just 0.5% in men [8] Research from the University of British Columbia shows that people who use semaglutide have a 52% higher chance of hair loss compared to those taking older weight loss medications [9]
In addition to avoiding potential issues like constipation, dry skin, or lightheadedness, adequate water intake is important because its associated with satiety and fullness as well
In this blog, well explore the best foods to eat while on semaglutide, strategies to understand the best foods to eat while taking semaglutide , create a supportive meal plan, and an FAQ section to address common concerns
Other less common side effects include: While semaglutide is generally considered safe, there are some precautions to keep in mind
Zhao J, Gao P, Zhu D (2010) Optimization of Zn2+-containing mobile phase for simultaneous determination of kynurenine, kynurenic acid and tryptophan in human plasma by high performance liquid chromatography
